Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Unlabelled: Generalized pustular psoriasis (GPP), as a rare type of life-threatening psoriasis with currently no effective treatment, imposes a huge economic burden on the healthcare systems. This systematic review aimed to summarize studies on the economic burden of GPP and the corresponding key cost drivers. A systematic search was conducted on PubMed, Web of Science, and Scopus for eligible studies published between 1st January 2000 and 31st December 2024. We strictly followed the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. Among the 324 studies identified, ten eligible studies describing the direct and indirect healthcare costs of GPP across five countries were included in this review. This study demonstrated that the average annual cost associated with GPP spans a wide range, with a mean of USD 23,675 (SD:16,691) [range: 7,791 − 49,891]. Based on the pool estimation, the leading cost drivers for GPP were the costs of inpatient admissions and medications. More than half of GPP patients (54.8%) were on topical steroids, 38.8% were on systemic non-biologic agents, and 14.8% were on biologic agents. For biologic agents, the highest usage was observed in the United States, and lowest usage was observed in China. In conclusion, this systematic review highlights the significant economic burden associated with GPP globally, mainly driven by the costs of admissions and medications. The review also demonstrates the challenges in GPP treatment, including the frequent use of systemic corticosteroids and limited access to newer biologic agents.
Supplementary Information: The online version contains supplementary material available at 10.1186/s13561-025-00670-3.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12403385 | PMC |
| http://dx.doi.org/10.1186/s13561-025-00670-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluating Telepsychiatric Assessment Satisfaction in Children and Adolescents With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder and Their Caregivers: Randomized Controlled Trial.
JMIR Pediatr Parent
September 2025
Center for the Promotion of Interdisciplinary Research in Medicine and Life Science, Keio University School of Medicine, Mori JP Tower F7, 1-3-1, Azabudai, Minato-ku, Tokyo, 160-0041, Japan, 81 353633219.
Background: Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) often face structural and psychological barriers in accessing medical care, including economic costs, long wait times, and stress of attending new medical environments. The COVID-19 pandemic accelerated the adoption of telehealth services to overcome these challenges. However, few studies have assessed the satisfaction levels of children and adolescents diagnosed with neurodevelopmental disorders and their caregivers when they use telepsychiatry, particularly in Japan.
View Article and Find Full Text PDFAugmenting water quality resilience in water distribution systems: A stress-driven model for ice slurry pigging optimisation strategy.
Water Res
August 2025
College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China; Shanghai Institute of Pollution Control and Ecological Security, Shanghai, China. Electronic address:
Pipeline cleaning is essential for maintaining water quality and safeguarding public health within water distribution networks. Although ice slurry pigging is widely adopted due to its effectiveness and environmental advantages, challenges remain in accurately quantifying cleaning efficacy and optimising maintenance intervals. This study develops a stress-driven wall material removal model calibrated using field-measured turbidity data, allowing for a comprehensive assessment of cleaning effectiveness based on post-cleaning shear resistance.
View Article and Find Full Text PDFEffect of forefoot strike and toe-out running on hip contact forces: A musculoskeletal modelling-based study.
J Biomech
September 2025
Human Movement Laboratory, School of Health Sciences, Western Sydney University, Campbelltown, NSW, Australia; Translational Health Research Institute, School of Health Sciences, Western Sydney University, Campbelltown, NSW, Australia.
Hip osteoarthritis (OA) is an increasingly significant public health concern, contributing to substantial economic and societal burden worldwide. Emerging evidence suggests that running may promote cartilage health through optimal joint loading. However, it remains unclear how modifications to running posture, such as altering footstrike patterns or adjusting foot progression angles, affect hip contact forces (HCF).
View Article and Find Full Text PDFPhenylketonuria: A guide through the complex maze of its neurological pathophysiology providing a new perspective on treatment strategies.
Biomed Pharmacother
September 2025
Liver Therapy & Evolution Team, In Vitro Toxicology and Dermato-Cosmetology (IVTD) Research Group, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels B-1090, Belgium. Electronic address:
Phenylketonuria (PKU), an autosomal recessive disease caused by a deficiency in the phenylalanine-4-hydroxylase enzyme or its cofactor tetrahydrobiopterin, is characterized by excessive phenylalanine (Phe) and reduced tyrosine (Tyr) levels and typically manifests neurologically. Even early treated PKU patients with proper metabolic control, obtained immediately after birth upon diagnosis of the disease, show late-onset neurological complications. Although the disease has already been researched for over 90 years, the complexity of its neurological pathophysiology has only recently been unraveled.
View Article and Find Full Text PDFNeuroavailable peptides from hempseed protein hydrolysates reduce hippocampal inflammation and glial activation in a scopolamine-induced Alzheimer's disease.
Biomed Pharmacother
September 2025
Department of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, University of Seville, Spain; Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, 41013, Spain. Electronic address:
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive impairment, synaptic dysfunction, and neuronal loss. Neuroinflammation, driven by the activation of microglia and astrocytes, is a key contributor to AD pathology, amplifying oxidative stress and amyloid-β toxicity. Modulation of neuroinflammatory pathways thus represents a promising therapeutic strategy.
View Article and Find Full Text PDF